Cryptococcosis complicating diabetes mellitus: a scoping review
- PMID: 33996076
- PMCID: PMC8111545
- DOI: 10.1177/20499361211014769
Cryptococcosis complicating diabetes mellitus: a scoping review
Abstract
Background: A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to Cryptococcus neoformans. Risk factors and outcomes of cryptococcosis in DM are not well documented.
Objective: The objective of this study was to determine the clinical characteristics and outcomes of cryptococcal infections in persons living with DM.
Methods: MEDLINE (via PubMed), EMBASE, and the Cochrane Library databases were searched in November 2020. The searches covered the period between 1980 and 2020.We included studies that reported confirmed cryptococcosis in patients with DM. Reference lists of included articles were also searched, and additional studies were included if appropriate. No language restriction was applied. Single case reports, case series and original articles were included whereas review articles were excluded.
Results: A total of 28 studies (24 single case reports, 4 retrospectives) were included involving 47 unique patients from Asia (17 cases), North America (six cases), South America (three cases) and Africa (two cases). Men constituted 75% (n = 18) of the cases. Median age was 60.5 (range: 27-79) years. The majority of the patients had cryptococcal meningitis (68.1%, n = 32) followed by disseminated cryptococcosis (6.4%, n = 7), and others (isolated cutaneous disease one, peritonitis one, pleural one, thyroid one, adrenal one). Diagnosis was achieved through either culture and microscopy (38/47), cryptococcal antigen tests (9/47) or histopathology (9/47) singly or in a combination. All-cause mortality was 38.3% (n = 18). Among those with meningitis mortality was 36.2%.
Conclusion: A wide spectrum of cryptococcal infections with varying severity occurs in DM. Mortality remains unacceptably high. There is a need for more studies to characterize better cryptococcal disease in DM.
Keywords: clinical characteristics; cryptococcosis; diabetes mellitus; mortality.
© The Author(s), 2021.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Similar articles
-
Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology.J Med Microbiol. 2004 Sep;53(Pt 9):935-940. doi: 10.1099/jmm.0.05427-0. J Med Microbiol. 2004. PMID: 15314203
-
COVID-19 associated with cryptococcosis: a scoping review.Ther Adv Infect Dis. 2024 Feb 14;11:20499361241232851. doi: 10.1177/20499361241232851. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 38361915 Free PMC article.
-
[Cryptococcal meningitis in patients with diabetes and AIDS].Enferm Infecc Microbiol Clin. 2014 Dec;32(10):643-6. doi: 10.1016/j.eimc.2013.11.001. Epub 2013 Dec 21. Enferm Infecc Microbiol Clin. 2014. PMID: 24365474 Spanish.
-
Clinical study of 23 pediatric patients with cryptococcosis.Eur Rev Med Pharmacol Sci. 2015 Oct;19(20):3801-10. Eur Rev Med Pharmacol Sci. 2015. PMID: 26531262
-
Cryptococcal Meningitis in Young, Immunocompetent Patients: A Single-Center Retrospective Case Series and Review of the Literature.Open Forum Infect Dis. 2023 Aug 11;10(8):ofad420. doi: 10.1093/ofid/ofad420. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37636518 Free PMC article. Review.
Cited by
-
Case report: A diabetic patient with cryptococcal meningoencephalitis complicated by post-infectious inflammatory response syndrome.Front Immunol. 2024 Nov 27;15:1444486. doi: 10.3389/fimmu.2024.1444486. eCollection 2024. Front Immunol. 2024. PMID: 39664376 Free PMC article.
-
Concomitant of Cryptococcal Meningitis and COVID-19 in a Female Patient with Primary Nephrotic Syndrome and Type 2 Diabetes.Risk Manag Healthc Policy. 2024 Jan 31;17:279-285. doi: 10.2147/RMHP.S451991. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 38313397 Free PMC article.
-
Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non-transplant Patients, a Propensity Score Match Analysis.Curr Microbiol. 2023 Oct 31;80(12):396. doi: 10.1007/s00284-023-03512-9. Curr Microbiol. 2023. PMID: 37907808
-
Isolated Cryptococcal Infection of the Thoracic Spine in an Immunocompetent Patient.Infect Drug Resist. 2024 Jul 24;17:3219-3224. doi: 10.2147/IDR.S472521. eCollection 2024. Infect Drug Resist. 2024. PMID: 39076349 Free PMC article.
-
Cryptococcal Meningitis Diagnosed With Lumbar Puncture in an Emergency Department Patient With Acute Delirium.Cureus. 2023 Sep 20;15(9):e45603. doi: 10.7759/cureus.45603. eCollection 2023 Sep. Cureus. 2023. PMID: 37868464 Free PMC article.
References
-
- Li SS, Mody CH. Cryptococcus. Proc Am Thorac Soc 2010; 7: 186–196. - PubMed
-
- Emmons CW. Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia). Am J Hyg 1955; 62: 227–232. - PubMed
-
- Evans EE. The antigenic composition of Cryptococcus neoformans: I. A serologic classification by means of the capsular and agglutination reactions. J Immunol 1950; 64: 423–430. - PubMed
-
- Meyer W, Gilgado F, Ngamskulrungroj P, et al.. Molecular typing of the Cryptococcus neoformans/Cryptococcus gattii species complex. In: Heitman J, Kozel TR, Kwon-Chung KJ, et al.. (eds) Cryptococcus: from human pathogen to model yeast. Wiley Online Books, 2011, pp. 327–357.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources